Propel Bio Management, LLC / DAWNGBX
Propel Bio Management, LLC’s Day One Biopharmaceuticals I Position
Does Propel Bio Management, LLC own Day One Biopharmaceuticals I (DAWNGBX)? Not currently — the last reported position was 270.7K shares worth $4M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q1 2024
Shares
270.7K
% of Portfolio
+2.60%
Quarters Held
2
position exited
Position History DAWNGBX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of DAWNGBX.